Next Article in Journal
Newborn Screening for Primary T- and B-Cell Immune Deficiencies—A Prospective Study in Andalucía
Previous Article in Journal
Phenylketonuria and Hirschsprung Disease—A Report of an Unusual Neonatal Presentation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

An Important Factor—Impact

Swiss Newborn Screening Laboratory, Children’s Research Center, University Children’s Hospital, Steinwiesstrasse 75, CH-8032 Zurich, Switzerland
Int. J. Neonatal Screen. 2017, 3(4), 26; https://doi.org/10.3390/ijns3040026
Submission received: 26 September 2017 / Revised: 26 September 2017 / Accepted: 26 September 2017 / Published: 28 September 2017
“Third time is a charm”—with this adage, we introduced the International Journal of Neonatal Screening (IJNS) nearly 3 years ago. I promised that IJNS would have a big impact in the field of newborn screening, and it has. By mid-September we had published 50 manuscripts in various categories, 43 of them were peer reviewed, with a total of 40,637 abstract views, 24,413 full-text views, and in total articles from IJNS have already been cited 39 times in other peer-reviewed journals. In addition, three articles from IJNS, which were NIH funded, are already indexed in PubMed (see below). We also have two societies that publish their annual symposium abstract in IJNS; this is (of course) ISNS, and the German society for neonatal screening (DGNS).
These results already show the big impact that our journal has made, and we are now on the home straight for indexing in Scopus and PubMed, which will also lead to an impact factor. So, we are quite sure that we will be able to apply for these in 2018. Therefore, I would like to thank all our colleagues that choose IJNS for the publication of their manuscripts, and congratulate them on the huge number of downloads of their work.
Finally, we are very pleased to mention, in more detail, those three published papers in Int. J. Neonatal Screen, that have been indexed by PubMed database to date:
The Newborn Screening Quality Assurance Program at the Centers for Disease Control and Prevention: Thirty-Five Year Experience Assuring Newborn Screening Laboratory Quality [1].
By De Jesús, V.R.; Mei, J.V.; Cordovado, S.K.; Cuthbert, C.D. Int. J. Neonatal Screen. 2015, 1, 13–26. doi:10.3390/ijns1010013. https://www.mdpi.com/2409-515X/1/1/13.
This paper has been viewed about 3000 times, and the full paper has been downloaded more than 1700 times. Furthermore, this paper has also been cited six times and referenced by “Newborn Screening Quality Assurance Program annual summary report 2015”.
Newborn Screening for Lysosomal Storage Diseases: A Concise Review of the Literature on Screening Methods, Therapeutic Possibilities and Regional Programs [2].
By Schielen, P.C.J.I.; Kemper, E.A.; Gelb, M.H. Int. J. Neonatal Screen. 2017, 3, 6. doi:10.3390/ijns3020006. https://www.mdpi.com/2409-515X/3/2/6.
Although it was published this year, it has already been viewed almost 1000 times and the full paper has been downloaded more than 650 times. This paper has also been cited four times.
Utility of Genetic Testing for Confirmation of Abnormal Newborn Screening in Disorders of Long-Chain Fatty Acids: A Missed Case of Carnitine Palmitoyltransferase 1A (CPT1A) Deficiency [3].
By Dowsett, L.; Lulis, L.; Ficicioglu, C.; Cuddapah, S. Int. J. Neonatal Screen. 2017, 3, 10. doi:10.3390/ijns3020010. https://www.mdpi.com/2409-515X/3/2/10.
This paper has also been viewed about 500 times and the full paper has been downloaded more than 160 times.
Please join in us in celebrating this good news and congratulating these authors on their contributions!

References

  1. De Jesús, V.R.; Mei, J.V.; Cordovado, S.K.; Cuthbert, C.D. The newborn screening quality assurance program at the centers for disease control and prevention: Thirty-five year experience assuring newborn screening laboratory quality. Int. J. Neonatal Screen. 2015, 1, 13–26. [Google Scholar] [CrossRef] [PubMed]
  2. Schielen, P.C.J.I.; Kemper, E.A.; Gelb, M.H. Newborn screening for lysosomal storage diseases: A concise review of the literature on screening methods, therapeutic possibilities and regional programs. Int. J. Neonatal Screen. 2017, 3, 6. [Google Scholar] [CrossRef] [PubMed]
  3. Dowsett, L.; Lulis, L.; Ficicioglu, C.; Cuddapah, S. Utility of Genetic Testing for Confirmation of Abnormal Newborn Screening in Disorders of Long-Chain Fatty Acids: A Missed Case of Carnitine Palmitoyltransferase 1A (CPT1A) Deficiency. Int. J. Neonatal Screen. 2017, 3, 10. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Fingerhut, R. An Important Factor—Impact. Int. J. Neonatal Screen. 2017, 3, 26. https://doi.org/10.3390/ijns3040026

AMA Style

Fingerhut R. An Important Factor—Impact. International Journal of Neonatal Screening. 2017; 3(4):26. https://doi.org/10.3390/ijns3040026

Chicago/Turabian Style

Fingerhut, Ralph. 2017. "An Important Factor—Impact" International Journal of Neonatal Screening 3, no. 4: 26. https://doi.org/10.3390/ijns3040026

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop